Abstract
When I graduated from medical school in 1946 the diagnosis of leukemia was a sentence of death. There were two developments near the end of the 1940s which were destined to change this dismal outlook. The first was the demonstration by Farber et al. [1] that a remission could be induced in children with acute lymphoblastic leukemia (ALL) by the use of an anti-folic antimetabolite. The second was the demonstration by Jacobson et al. [2] that mice could be protected from otherwise lethal irradiation by shielding the spleen, an observation that eventually led to the recognition of the potential role of marrow transplantation in the treatment of leukemia.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Farber S, Diamond LK, Mercer RD, Sylvester RF Jr., Wolff JA (1948) Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4 — aminopteroyl — g1utamic acid (aminopterin). N Engl J Med 238: 787–791
Jacobson LO, Marks EK, Robsen MJ, Gaston EO, Zirkle RE (1949) Effect of spleen protection on mortality following x-irradiation. J Lab Clin Med 34: 1538–1543
Thomas ED, Storb R, Clift RA, Fefer A, Johnson FL, Neiman PE, Lerner KG, Glucksberg H, Buckner CD (1975) Bone-marrow transplantation. N Engl J Med 292: 832–843, 895–902
Thomas ED, Flournoy N, Buckner CD, Clift RA, Fefer A, Neiman PE, Storb R (1977) Cure of leukemia by marrow transplantation. Leuk Res 1: 67–70
Powles RL, Morgenstern G, Clink HM, Hedley D, Bandini G, Lumley H, Watson JG, Lawson D, Spence D, Barrett A, Jameson B, Lawler S, Kay HEM, McElwain TJ (1980) The place of bone-marrow transplantation in acute myelogenous leukaemia. Lancet i: 1047–1050
Champlin RE, Ho WG, Gale RP, Winston D, Selch M, Mitsuyasu R, Lenarsky C, Elashoff R, Zighelboim J, Feig SA (1985) Treatment of acute myelogenous leukemia. A prospective controlled trial of bone marrow transplantation versus consolidation chemotherapy. Ann Intern Med 102: 285–291
Ringdén O, Bolme P, Lönnqvist B, Gustafsson G, Kreuger A (1992) Allogeneic bone marrow transplantation versus chemotherapy in children with acute leukemia in Sweden. Ped Hematol Oncol 6: 137–144
Appelbaum FR, Fisher LD, Thomas ED, and the Seattle Marrow Transplant Team (1988) Chemotherapy v marrow transplantation for adults with acute non lymphocytic leukemia: A five-year follow-up. Blood 72: 179–184
Dahl GV, Kalwinsky DK, Mirro J, Jr., Look AT, Pui C-H, Murphy SB, Mason C, Ruggiero M, Schell M, Johnson FL, Thomas ED (1990) Allogeneic bone marrow transplantation in a program of intensive sequential chemotherapy for children and young adults with acute nonlymphocytic leukemia in first remission. J Clin Oncol 8: 295–303
Nesbit ME, Jr., Buckley J, Feig SA, Anderson J, Lampkin B, Bernstein ID, Kim TH, Piomelli S, Kersey JH, Coccia PF, O’Reilly RJ, August C, Thomas ED, Hammond GO: Chemotherapy for induction of remission of childhood acute myeloid leukemia followed by marrow transplantation or multi-agent chemotherapy. A report from the Children’s Study Group. (Manuscript in preparation)
Appelbaum FR, Hewlett J, Kopecky K, Angle C, Coltman C (1986) Prospective comparative study of bone marrow transplantation (BMT) versus continued chemotherapy for adult acute nonlymphocytic leukemia (ANL): A southwest oncology group study. Blood 68 (Supp. 1): 216a, (Abstract)
Creutzig U, Ritter J, Schellong G (1990) Identification of two risk groups in childhood acute myelogenous leukemia after therapy intensification in study AML-BFM-83 as compared with study AML-BFM-78. Blood 75: 1932–1940
Tallman MS, Kopecky KJ, Amos D, Dahlberg S, Hewlett JS, Files JC, Coltman CA, Thomas ED, Appelbaum FR (1989) Analysis of prognostic factors for the outcome of marrow transplantation or further chemotherapy for patients with acute nonlymphocytic leukemia in first remission. J Clin Oncol 7: 326–337
Horowitz MM, Messerer D, Hoelzer D, Gale RP, Neiss A, Atkinson K, Barrett AJ, Büchner T, Freund M, Heil G, Hiddemann W, Kolb H-J, Löffer H, Marmont AM, Maschmeyer G, Rimm AA, Rozman C, Sobocinski KA, Speck B, Thiel E, Weisdorf DJ, Zwaan FE, Bortin MM (1991) Chemotherapy compared with bone marrow transplantation for adults with acute lymphoblastic leukemia in first remission. Ann Intern Med 115: 13–18
Thomas ED, Buckner CD, Banaji M, Clift RA, Fefer A, Flournoy N, Goodell BW, Hickman RO, Lerner KG, Neiman PE, Sale GE, Sanders JE, Singer J, Stevens M, Storb R, Weiden PL (1977) One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. Blood 49: 511–533
Appelbaum FR, Clift RA, Buckner CD, Stewart P, Storb R, Sullivan KM, Thomas ED (1983) Allogeneic marrow transplantation for acute nonlymphoblastic leukemia after first relapse. Blood 61: 949–953
Thomas ED, Sanders JE, Flournoy N, Johnson FL, Buckner CD, Clift RA, Fefer A, Goodell BW, Storb R, Weiden PL (1979) Marrow transplantation for patients with acute lymphoblastic leukemia in remission. Blood 54: 468–476
Johnson FL, Thomas ED, Clark BS, Chard RL, Hartmann JR, Storb R (1981) A comparison of marrow transplantation with chemotherapy for children with acute lymphoblastic leukemia in second or subsequent remission. N Engl J Med 305: 846–851.
Sanders JE, Thomas ED, Buckner CD, Doney K (1987) Marrow transplantation for children with acute lymphoblastic leukemia in second remission. (Concise Report). Blood 70: 324–326
Dopfer R, Henze G, Bender-Götze C, Bell W, Ehninger G, Friedrich W, Gadner H, Klingebiel T, Peters C, Riehm H, Suttorp M, Schmid H, Schmitz N, Siegert W, Stollman-Gibbels B, Hartmann R, Niethammer D (1991) Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM- and CoALL-Protocols: Results of the German Cooperative Study. Blood 78: 2780–2784
Wade JC, Newton B, McLaren C, Flournoy N, Keeney RE, Meyers JD (1982) Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation: A double-blind trial. Ann Intern Med 96: 265–269
Schmidt GM, Horak DA, Niland JC, Duncan SR, Forman SJ, Zaia JA (1991) A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants. N Engl J Med 324: 1005–1011
Nemunaitis J, Rabinowe SN, Singer JW, Bierman PJ, Vose JM, Freedman AS, Onetto N, Gillis S, Oette D, Gold M, Buckner CD, Hansen JA, Ritz J, Appelbaum FR, Armitage JO, Nadler LM (1991) Recombinant granulocyte-macrophage colony-stimulating factor after autologous bone marrow transplantation for lymphoid cancer. N Engl J Med 324: 1773–1778
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Thomas, E.D. (1994). The Treatment of Acute Leukemia: Observations by a Marrow Transplanter. In: Büchner, T., Hiddemann, W., Wörmann, B., Schellong, G., Ritter, J. (eds) Acute Leukemias IV. Haematology and Blood Transfusion / Hämatologie und Bluttransfusion, vol 36. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78350-0_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-78350-0_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-78352-4
Online ISBN: 978-3-642-78350-0
eBook Packages: Springer Book Archive